关注
Uday B. Kompella
Uday B. Kompella
Professor of Pharmaceutical Sciences
在 ucdenver.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Nanomicellar formulations for sustained drug delivery: strategies and underlying principles
R Trivedi, UB Kompella
Nanomedicine 5 (3), 485-505, 2010
3892010
Recent advances in ophthalmic drug delivery
UB Kompella, RS Kadam, VHL Lee
Therapeutic delivery 1 (3), 435-456, 2010
3462010
Mucosal penetration enhancers for facilitation of peptide and protein drug absorption.
VH Lee, A Yamamoto, UB Kompella
Critical reviews in therapeutic drug carrier systems 8 (2), 91, 1991
3391991
Subconjunctival nano-and microparticles sustain retinal delivery of budesonide, a corticosteroid capable of inhibiting VEGF expression
UB Kompella, N Bandi, SP Ayalasomayajula
Investigative ophthalmology & visual science 44 (3), 1192-1201, 2003
3352003
Microfluidic devices for drug delivery systems and drug screening
S Damiati, UB Kompella, SA Damiati, R Kodzius
Genes 9 (2), 103, 2018
3272018
Periocular routes for retinal drug delivery
S Raghava, M Hammond, UB Kompella
Expert opinion on drug delivery 1 (1), 99-114, 2004
3272004
Presenilin 1 maintains lysosomal Ca2+ homeostasis via TRPML1 by regulating vATPase-mediated lysosome acidification
JH Lee, MK McBrayer, DM Wolfe, LJ Haslett, A Kumar, Y Sato, PPY Lie, ...
Cell reports 12 (9), 1430-1444, 2015
3252015
Ophthalmic drug delivery systems for the treatment of retinal diseases: basic research to clinical applications
HF Edelhauser, CL Rowe-Rendleman, MR Robinson, DG Dawson, ...
Investigative ophthalmology & visual science 51 (11), 5403-5420, 2010
3132010
Nanoparticle technology for drug delivery
RB Gupta, UB Kompella
Taylor & Francis Group, LLc, 2006
2982006
Nasal route for direct delivery of solutes to the central nervous system: fact or fiction?
S Mathison, R Nagilla, UB Kompella
Journal of drug targeting 5 (6), 415-441, 1998
2901998
Nanomedicines for back of the eye drug delivery, gene delivery, and imaging
UB Kompella, AC Amrite, RP Ravi, SA Durazo
Progress in retinal and eye research 36, 172-198, 2013
2822013
Development and in-vitro evaluation of sustained release poloxamer 407 (P407) gel formulations of ceftiofur
L Zhang, DL Parsons, C Navarre, UB Kompella
Journal of Controlled Release 85 (1-3), 73-81, 2002
2502002
Intravenous transferrin, RGD peptide and dual-targeted nanoparticles enhance anti-VEGF intraceptor gene delivery to laser-induced CNV
SR Singh, HE Grossniklaus, SJ Kang, HF Edelhauser, BK Ambati, ...
Gene therapy 16 (5), 645-659, 2009
2422009
Size-dependent disposition of nanoparticles and microparticles following subconjunctival administration
AC Amrite, UB Kompella
Journal of pharmacy and pharmacology 57 (12), 1555-1563, 2005
2402005
Preparation of drug delivery systems using supercritical fluid technology
UB Kompella, K Koushik
Critical Reviews™ in Therapeutic Drug Carrier Systems 18 (2), 2001
2282001
Hybrid dendrimer hydrogel/PLGA nanoparticle platform sustains drug delivery for one week and antiglaucoma effects for four days following one-time topical administration
H Yang, P Tyagi, RS Kadam, CA Holden, UB Kompella
ACS nano 6 (9), 7595-7606, 2012
2142012
Single periocular injection of celecoxib-PLGA microparticles inhibits diabetes-induced elevations in retinal PGE2, VEGF, and vascular leakage
AC Amrite, SP Ayalasomayajula, NPS Cheruvu, UB Kompella
Investigative ophthalmology & visual science 47 (3), 1149-1160, 2006
2022006
Celecoxib, a selective cyclooxygenase-2 inhibitor, inhibits retinal vascular endothelial growth factor expression and vascular leakage in a streptozotocin-induced diabetic rat …
SP Ayalasomayajula, UB Kompella
European journal of pharmacology 458 (3), 283-289, 2003
2022003
Effect of circulation on the disposition and ocular tissue distribution of 20 nm nanoparticles after periocular administration
AC Amrite, HF Edelhauser, SR Singh, UB Kompella
Molecular vision 14, 150, 2008
1852008
Subconjunctivally administered celecoxib-PLGA microparticles sustain retinal drug levels and alleviate diabetes-induced oxidative stress in a rat model
SP Ayalasomayajula, UB Kompella
European journal of pharmacology 511 (2-3), 191-198, 2005
1772005
系统目前无法执行此操作,请稍后再试。
文章 1–20